X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (11) 11
female (7) 7
male (6) 6
aged (5) 5
animals (5) 5
middle aged (5) 5
adult (4) 4
aged, 80 and over (4) 4
hematology (4) 4
mutation (4) 4
prognosis (4) 4
adolescent (3) 3
genetic aspects (3) 3
jak2 (3) 3
risk (3) 3
young adult (3) 3
available therapy (2) 2
biochemistry & molecular biology (2) 2
biomarkers - blood (2) 2
cardiac & cardiovascular systems (2) 2
child (2) 2
chronic disease (2) 2
disease (2) 2
enhancer of zeste homolog 2 protein (2) 2
epidemiology (2) 2
gene (2) 2
gene mutations (2) 2
genes (2) 2
genetics (2) 2
genotype (2) 2
health aspects (2) 2
heart failure - diagnosis (2) 2
immunologic factors - administration & dosage (2) 2
immunologic factors - adverse effects (2) 2
international working group (2) 2
italy - epidemiology (2) 2
jc virus (2) 2
jc virus - isolation & purification (2) 2
medical research (2) 2
medicine, research & experimental (2) 2
mice (2) 2
multiple sclerosis (2) 2
myeloproliferative disorders - genetics (2) 2
myeloproliferative neoplasms (2) 2
natalizumab (2) 2
natalizumab - administration & dosage (2) 2
natalizumab - adverse effects (2) 2
plasma-exchange (2) 2
polycomb repressive complex 2 (2) 2
prevalence (2) 2
primary myelofibrosis (2) 2
primary myelofibrosis - genetics (2) 2
primary myelofibrosis - mortality (2) 2
productive infection (2) 2
progressive multifocal leukoencephalopathy (2) 2
risk assessment (2) 2
risk factors (2) 2
safety (2) 2
settore med/11 - malattie dell'apparato cardiovascolare (2) 2
survival rate (2) 2
t-cells (2) 2
transcription factors - genetics (2) 2
treatment outcome (2) 2
11 (1) 1
abridged index medicus (1) 1
academic libraries (1) 1
activation (1) 1
acute disease (1) 1
adolescent; adult; aged; aged, 80 and over; child; child, preschool; eye proteins; female; genetic counseling; genotype; high-throughput nucleotide sequencing; humans; male; middle aged; mutation; pathology, molecular; pedigree; retinal dystrophies; retinitis pigmentosa; young adult; immunology and microbiology; biochemistry, genetics and molecular biology (1) 1
adrenal cortex hormones - therapeutic use (1) 1
adverse events (1) 1
alcohol drinking - adverse effects (1) 1
alcohol drinking - epidemiology (1) 1
alcohol drinking - psychology (1) 1
alternative splicing (1) 1
alternative splicing; gene expression; muscle differentiation; nf-y; transcription factor; animals; ccaat-binding factor; cell differentiation; cell proliferation; cyclin b; gene expression regulation, developmental; hematopoietic stem cells; humans; mice; muscle development; muscle, skeletal; myoblasts; promoter regions, genetic; protein isoforms; transcription factors; biochemistry; biophysics; genetics; molecular biology; structural biology; medicine (1) 1
alternative splicing; gene expression; muscle differentiation; nf-y; transcription factor; animals; ccaat-binding factor; cell differentiation; cell proliferation; cyclin b; gene expression regulation, developmental; hematopoietic stem cells; humans; mice; muscle development; muscle, skeletal; myoblasts; promoter regions, genetic; protein isoforms; transcription factors; structural biology; biophysics; biochemistry; molecular biology; genetics (1) 1
amino acids (1) 1
analysis (1) 1
angiogenesis (1) 1
animals, newborn (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
arginine - metabolism (1) 1
article subject (1) 1
biochemistry (1) 1
biological markers (1) 1
biological markers; quality of life; wine; aged; alcohol drinking; biomarkers; chronic disease; comorbidity; depression; female; heart failure; humans; italy; male; middle aged; prevalence; prognosis; protective factors; risk assessment; risk factors; stroke volume; surveys and questionnaires; vasculitis; ventricular function, left; health status; quality of life; wine; cardiology and cardiovascular medicine (1) 1
biophysics (1) 1
biotechnology & applied microbiology (1) 1
blood glucose - metabolism (1) 1
brain (1) 1
bronchopulmonary dysplasia (1) 1
calr (1) 1
calreticulin mutations (1) 1
cancer; ngs; sequencing; myeloproliferative neoplasms; exome (1) 1
cardiovascular-disease (1) 1
care and treatment (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2017, Volume 18, Issue 5, p. 940
Natalizumab is a monoclonal antibody highly effective in the treatment of relapsing remitting multiple sclerosis (RRMS) patients. Despite its effectiveness,... 
Natalizumab management | Long term safety | Natalizumab discontinuation | Natalizumab | Therapeutic switch | Progressive multifocal leukoencephalopathy | therapeutic switch | INTEGRIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | long term safety | JC VIRUS | TREATMENT INTERRUPTION | natalizumab discontinuation | PRODUCTIVE INFECTION | CHEMISTRY, MULTIDISCIPLINARY | DISEASE-ACTIVITY | PREGNANCY | PLASMA-EXCHANGE | progressive multifocal leukoencephalopathy | natalizumab management | natalizumab | MS PATIENTS | T-CELLS | Humans | Natalizumab - adverse effects | Antibodies, Monoclonal - adverse effects | Immunologic Factors - administration & dosage | Antibodies, Monoclonal - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Leukoencephalopathy, Progressive Multifocal - diagnosis | Animals | Antibodies, Monoclonal - administration & dosage | Natalizumab - administration & dosage | Natalizumab - therapeutic use | JC Virus - isolation & purification | Leukoencephalopathy, Progressive Multifocal - etiology | Immunologic Factors - adverse effects | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Drugs | Medical research | Brain | Multiple sclerosis | Clinical trials | Case reports | Viruses | Risk | Management | Patients | Leukoencephalopathy | Immunosuppressive agents | Monoclonal antibodies
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2016, Volume 91, Issue 7, pp. 681 - 686
Journal Article
BioMed Research International, ISSN 2314-6133, 2016, Volume 2016, pp. 6341870 - 14
Journal Article
Blood, ISSN 0006-4971, 04/2014, Volume 123, Issue 14, pp. 2157 - 60
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 2876 - 2876
Abstract Abstract 2876 Multiple myeloma (MM) is a malignancy of abnormal plasma cells and a correlation with poor outcome has been described for immunoglobulin... 
Journal Article
Lung, ISSN 0341-2040, 8/2012, Volume 190, Issue 4, pp. 419 - 430
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 2548 - 2548
Abstract Abstract 2548 Introduction: At present, the diagnosis of T-ALL is based on immunophenotyping and specific chromosomal rearrangements. However, the... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 1783 - 1783
Abstract Abstract 1783 TP53 is one of the most important cell-cycle regulator genes and its tumor suppressor activity is fundamental in cellular responses.... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 3440 - 3440
Abstract Abstract 3440 The t(10;11)(p13;q14)/PICALM-MLLT10 (CALM-AF10) rearrangement is most frequently associated with T-lineage acute lymphoblastic... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 107 - 107
Abstract Background Ruxolitinib (RUX) is a JAK1 & JAK2 inhibitor that resulted in rapid and durable reductions in splenomegaly and improved disease-related... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 4099 - 4099
Abstract The discovery of the JAK2V617F mutation in 2005 [Kralovics R, N Engl J Med 2005] represented a major breakthrough in the understanding of the... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 405 - 405
Abstract BACKGROUND. In primary myelofibrosis (PMF), survival from time of diagnosis is predicted by the international prognostic scoring system (IPSS), and... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1867 - 1867
Abstract Background: We reported that mutations in ASXL1, EZH2, IDH1/2 and SRSF2 are negative prognostic variables for survival in primary myelofibrosis (PMF).... 
Journal Article